Inventor · disambiguated record
Kevin Thewlis
Also filed as: THEWLIS KEVIN · THEWLIS KEVIN M · THEWLIS KEVIN MICHAEL
13 granted patents·9 pending applications·73 citations·filing 2001–2018
88Inventor score
Files withGLAXO GROUP LTD10SMITHKLINE BEECHAM PLC4SMITHKLINE BEECHAM LTD2HAPLOGEN GMBH1THEWLIS KEVIN MICHAEL1
Top patents by PatentIndex Score
22 records- 0190US6677354B2Piperdines for use as orexin receptor antagonistsSMITHKLINE BEECHAM PLC·Filed 2001·Granted Jan 13, 2004·42 cites·18 claims
- 0283US6943160B2Morpholine derivatives as antagonists of orexin receptorsSMITHKLINE BEECHAM PLC·Filed 2001·Granted Sep 13, 2005·18 cites·13 claims
- 0377US7741329B2N-aroyl cyclic aminesSMITHKLINE BEECHAM LTD·Filed 2007·Granted Jun 22, 2010·2 cites·13 claims
- 0477US7642256B2Compounds which potentiate AMPA receptor and uses thereof in medicineGLAXO GROUP LTD·Filed 2008·Granted Jan 5, 2010·2 cites·4 claims
- 0574US7432270B2N-aroyl cyclic aminesSMITHKLINE BEECHAM PLC·Filed 2002·Granted Oct 7, 2008·6 cites·13 claims
- 0671US7790758B2Compounds which potentiate glutamate receptor and uses thereof in medicineGLAXO GROUP LTD·Filed 2006·Granted Sep 7, 2010·2 cites·15 claims
- 0767US7741351B2Compounds which potentiate glutamate receptor and uses thereof in medicineGLAXO GROUP LTD·Filed 2005·Granted Jun 22, 2010·1 cites·14 claims
- 0860US7919507B2N-aroyl cyclic aminesSMITHKLINE BEECHAM LTD·Filed 2007·Granted Apr 5, 2011·0 cites·8 claims
- 0959US7566735B2Compounds which potentiate AMPA receptor and uses thereof in medicineGLAXO GROUP LTD·Filed 2007·Granted Jul 28, 2009·0 cites·4 claims
- 1057US7572819B2Compounds which potentiate glutamate receptor and uses thereof in medicineGLAXO GROUP LTD·Filed 2007·Granted Aug 11, 2009·0 cites·10 claims
- 1149US7618969B2Compounds which potentiate glutamate receptor and uses thereof in medicineGLAXO GROUP LTD·Filed 2005·Granted Nov 17, 2009·0 cites·32 claims
- 1245US2004063686A1Carboxamide compounds and their use as antagonists of a human 11cby receptorFiled 2001·Application pending·0 cites
- 1344US2009221643A14-phenyl-3-(2-propylsulfonylamino) tetrahydrofuran derivatives which potentiate glutamate receptors and are useful in the treatment of schizophreniaTHEWLIS KEVIN MICHAEL·Filed 2007·Application pending·0 cites
- 1444US2010137276A1Compounds which potentiate ampa receptor and uses thereof in medicineGLAXO GROUP LTD·Filed 2007·Application pending·0 cites
- 1542US2005176724A1Piperidine and piperazine derivatives possessing affinity at 5ht-1 type receptorsFiled 2003·Application pending·0 cites
- 1642US2007270471A1Compounds Which Potentiate Glutamate Receptor and Uses Thereof in MedicineGLAXO GROUP LTD·Filed 2005·Application pending·0 cites
- 1741US2005107410A1Compound possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disordersFiled 2003·Application pending·0 cites
- 1840US2004192673A1N-aroyl cyclic amine derivatives as orexin receptor antagonistsFiled 2002·Application pending·0 cites
- 1940US2009270510A1Glycine transport inhibitorsGLAXO GROUP LTD·Filed 2005·Application pending·0 cites
- 2039US2010216837A1Glycine transport inhibitorsGLAXO GROUP LTD·Filed 2005·Application pending·0 cites
- 2137US6939871B2Benzoxazinone derivatives, their preparation and useSMITHKLINE BEECHAM PLC·Filed 2001·Granted Sep 6, 2005·0 cites·16 claims
- 2233US11180479B2Antiviral compoundsHAPLOGEN GMBH·Filed 2018·Granted Nov 23, 2021·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Kevin Thewlis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →